{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-106345","form_type":"8-K","ticker":"INKT","cik":"0001840229","company_name":"MiNK Therapeutics, Inc.","filed_at":"2024-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.830783+00:00","generated_at":"2026-05-31T05:00:00.359357+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MiNK Therapeutics receives Nasdaq MVLS deficiency notice; has until March 12, 2025 to comply","bullets":["Received Nasdaq letter on September 13, 2024 for failing MVLS (minimum value of listed securities) requirement.","MVLS was below $35 million for 30 consecutive trading days, violating Nasdaq Listing Rule 5550(b)(2).","Company has 180 calendar days, until March 12, 2025, to regain compliance.","To comply, MVLS must be $35M or more for at least 10 consecutive trading days.","Failure to cure may lead to delisting; company may then appeal to a Hearings Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-106345","json":"https://secwatch.observer/filing/0000950170-24-106345.json","markdown":"https://secwatch.observer/filing/0000950170-24-106345.md","text":"https://secwatch.observer/filing/0000950170-24-106345.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024106345/0000950170-24-106345-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840229/000095017024106345/inkt-20240913.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:00:00.359357+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}